FOLFIRI plus sunitinib versus FOLFIRI alone in advanced chemorefractory esophagogastric cancer patients: A randomized placebo-controlled multicentric AIO phase II trial.
Markus Hermann Moehler
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Other Remuneration - Pfizer
Peter C. Thuss-Patience
No relevant relationships to disclose
Hans-Joachim Schmoll
No relevant relationships to disclose
Susanna Hegewisch-Becker
No relevant relationships to disclose
Hansjochen Wilke
No relevant relationships to disclose
Salah-Eddin Al-Batran
No relevant relationships to disclose
Florian Weissinger
No relevant relationships to disclose
Frank Kullmann
No relevant relationships to disclose
Ludwig Fischer Von Weikersthal
No relevant relationships to disclose
Jens T. Siveke
No relevant relationships to disclose
Stephan Kanzler
No relevant relationships to disclose
Carl Christoph Schimanski
No relevant relationships to disclose
Melanie Otte
No relevant relationships to disclose
Lukas Schollenberger
No relevant relationships to disclose
Jochem Koenig
No relevant relationships to disclose
Peter Robert Galle
No relevant relationships to disclose